Penicillin-binding protein 3 (PBP3; also called FtsI) is a transpeptidase that catalyzes cross-linking of the peptidoglycan cell wall in the division septum of Escherichia coli. To determine whether the catalytic activity of PBP3 is activated during division, we assayed acylation of PBP3 with three ␤-lactams (cephalexin, aztreonam, and piperacillin) in growing cells. Acylation of PBP3 with cephalexin, but not aztreonam or piperacillin, appeared to be stimulated by cell division. Specifically, cephalexin acylated PBP3 about 50% faster in a population of dividing cells than in a population of filamentous cells in which division was inhibited by inactivation or depletion of FtsZ, FtsA, FtsQ, FtsW, or FtsN. However, in a simpler in vitro system using isolated membranes, acylation with cephalexin was not impaired by depletion of FtsW or FtsN. A conflicting previous report that the ftsA3(Ts) allele interferes with acylation of PBP3 was found to be due to the presence of a thermolabile PBP3 in the strain used in that study. The new findings presented here are discussed in light of the hypothesis that the catalytic activity of PBP3 is stimulated by interaction(s) with other division proteins. We suggest that there might be allosteric activation of substrate binding.
Cell division in Escherichia coli requires approximately 10 proteins that localize to a ring structure at the division site. Most of these proteins are named Fts for filamentation temperature sensitive, because appropriate mutants form long, aseptate filaments under nonpermissive conditions. The Fts proteins localize to the division site in a defined sequence ( Fig.  1) (8, 17, 23, 28, 30) . The process starts with assembly of the tubulin-like protein FtsZ into a contractile ring at the middle of the cell. Subsequent recruitment of the other division proteins is thought to result in assembly of a large complex that is directly responsible for synthesis of the division septum. Protein-protein interactions in this hypothetical complex presumably serve to recruit proteins to the division site and to regulate their activities once they are there. One of the last proteins to localize to the septal ring is penicillin-binding protein 3 (PBP3; also called FtsI) (41, 42) , a transpeptidase that catalyzes crosslinking of the peptidoglycan cell wall during division. Here we report on the use of a penicillin-binding assay in growing cells to test the idea that division proteins regulate the catalytic activity of PBP3.
␤-Lactam antibiotics are often used as substrates to measure the catalytic activity of PBP3, because the physiological substrates used by the enzyme are not yet known (1) . Some background will help clarify the principle of this assay. Transpeptidation is a two-step reaction. First, a serine residue (Ser307 of PBP3 [20, 27] ) attacks the acyl D-alanylOD-alanine bond of the donor peptide, resulting in the formation of an acyl enzyme intermediate and release of the terminal D-alanine. Subsequently, a primary amine in the acceptor peptide serves as the attacking nucleophile, with concomitant formation of a new peptide bond and release of the enzyme for further rounds of catalysis.
Many transpeptidases also react with ␤-lactam antibiotics, which mimic the acyl D-alanylOD-alanine bond (35) , but in this case the covalent acyl enzyme intermediate is essentially irreversible. Therefore, penicillin-binding proteins can be detected in polyacrylamide gels after treatment of whole cells or isolated membranes with a labeled ␤-lactam (33) . The name PBP3 reflects the observation that it is 1 of about 12 (depending on the conditions) E. coli proteins observed in such assays (12) . Because penicillin "binding" requires that the enzyme perform catalysis on the ␤-lactam, the assay gives some information on the catalytic state of the protein. For example, penicillin binding would not be observed if the catalytic serine were not activated to serve as a nucleophile or if the active site were occluded.
Evidence that the catalytic activity of PBP3 is indeed regulated in vivo comes from labeling studies using precursors of peptidoglycan (5, 44, 45) . These studies indicate that the protein only engages in peptidoglycan synthesis in the developing septum. This finding can be explained in part by timed localization of PBP3 to the division site (42) . However, while localization studies appear to account for the contribution of PBP3 towards septum assembly, they do not readily explain the apparent lack of a contribution to elongation of the peptidoglycan sacculus. This is an issue because PBP3 is present and distributed around the membrane in nondividing cells (43, 46) . Might PBP3's catalytic activity also be subject to allosteric regulation, such that the enzyme is turned on when it engages other division proteins at the middle of the cell? Several observations reported in the literature seem to support this possibility. One study reported that some fts mutations that block cell division render E. coli partially resistant to penicillin-induced lysis (29) . Another study found that the binding of 125 Ilabeled ampicillin to PBP3 in membranes derived from an ftsA3(Ts) mutant was eliminated when those membranes were incubated at the nonpermissive temperature, as might be expected if an FtsA-PBP3 interaction modulates PBP3's transpeptidase activity (36) . Finally, a double mutation in a putative regulatory domain of PBP3 abolishes penicillin-binding activity and prevents function in cell division (22) .
Nevertheless, it has been known for many years that PBP3 in isolated membranes acylates itself with numerous ␤-lactams (34) and that PBP3 reacts readily with some penicillins in growing cells, even when division is prevented by means of a temperature-sensitive mutation (5) . Although PBP3 cannot be engaged in cell division under these conditions, it might still interact with some other division proteins. More recently, a truncated form of PBP3 that lacks its N-terminal membrane anchor sequence has been purified and shown to react with ␤-lactams at rates similar to those observed when native PBP3 is studied in isolated membranes (1) . This finding argues against a requirement for allosteric activation, unless one supposes that the deletion itself activates the protein. Curiously, the truncated PBP3 protein is inert towards lipid II (1), the most plausible physiological substrate, implying that lipid II is not the substrate used in vivo or that the assay conditions are not correct (for example, maybe the other division proteins do activate PBP3 after all).
Several years ago, one of us (D. S. Weiss) was studying the effect of cephalexin on FtsZ ring formation in various fts mutants growing at the nonpermissive temperature. The question at the time was whether inactivation of PBP3 with an antibiotic would exacerbate the mild FtsZ ring defect observed when an fts mutant is grown at 42°C (by simultaneously inactivating two Fts proteins). It did not. Curiously, control experiments indicated that inactivation of ftsA or ftsQ slightly impaired cephalexin binding to PBP3. This suggested the interesting possibility that assembly of PBP3 into the hypothetical protein complex that mediates division stimulates the transpeptidase catalytic activity and thus reactivity towards cephalexin. pDSW520] reflects the order in which the plasmids were entered into our collection, rather than the order in which they were constructed.) Assays of ␤-lactam binding in growing cells. For strains depleted of Fts proteins, a 5-ml culture was grown overnight at 37°C in LB medium containing kanamycin, chloramphenicol, and 0.2% arabinose. The next morning, this culture was diluted 1:50 into 20 ml of the same medium and grown to an optical density at 600 nm (OD 600 ) of ϳ0.8. The cells were washed twice with LB medium to remove arabinose and then used to inoculate 20-ml cultures of LB medium plus antibiotics to a starting OD 600 of 0.005. Two flasks were inoculated for each concentration of ␤-lactam to be tested; one flask contained arabinose, while the other contained glucose. Cells were examined periodically in the microscope until the culture grown in glucose began to filament, which typically occurred about 3 h after subculturing, when the OD 600 was ϳ0.3. At this time, the ␤-lactam to be tested was added to each flask, and incubation was continued for 30 min.
In early experiments, we assessed the extent of ␤-lactam binding by resuspending cells in spheroplasting buffer and incubating with 10 M Bocillin FL essentially as described previously (16) . Later, Bocillin counterlabeling was done with isolated membranes prepared by extraction of soluble proteins with a nonionic detergent as follows. Cells from 2 ml of culture were pelleted in a microcentrifuge and resuspended in 120 l of BugBuster containing 25 U of Benzonase (Novagen, Madison, Wis.) per ml. The suspension was incubated at room temperature for 12 min, and then cell envelopes were pelleted in a microcentrifuge and resuspended in 50 mM Tris-HCl (pH 8.0) to an OD 600 of 20 (i.e., 2 ml of culture at an OD 600 of 0.5 was resuspended in 50 l). To counterlabel PBPs, 22.5 l of the membrane suspension was incubated with 2.5 l of 100 M Bocillin FL at 30°C for 20 min. Membranes were pelleted in a microcentrifuge, the supernatant containing unreacted Bocillin FL was discarded, and the pellet was resuspended in 20 l of 1ϫ Laemmli sample buffer for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Samples were analyzed on SDS-12% polyacrylamide gels and subjected to fluorescence scanning to detect proteins labeled with Bocillin FL. We switched from working with spheroplasts to membranes when we found that the latter gave us better sensitivity owing to reduced fluorescent background on gels. Detergent extraction resulted in reduced signal from PBP5 and possibly PBP1b under some conditions, so this method would not be suitable for studies of these proteins. In the case of PBP5, the loss of signal was due to extraction of the protein, as we were able to account for the missing protein in the supernatant. In the case of PBP1b, which is much lower in abundance and therefore harder to track, we do not know whether extraction removed the protein or inactivated it.
The procedures for temperature-sensitive mutants were similar except that cultures were grown at 30°C without antibiotics or added sugars to an OD 600 of ϳ0.5 and then diluted fivefold into two flasks, which were incubated at 30 and 42°C, respectively. Filamentation was apparent in the 42°C culture within about 30 min, at which time the test ␤-lactam was added to each flask.
When blocking of FtsZ ring formation was desired, the medium contained kanamycin to select for pDSW259, which expresses sulA under arabinose control. Duplicate cultures were grown at 37°C to an OD 600 of ϳ0.1, when arabinose was added. Filamentation was apparent after about 30 min, at which time a test ␤-lactam was added to each culture.
Assays of ␤-lactam binding in isolated membranes. To study the effects of FtsW and FtsN on PBP3's penicillin-binding activity, membranes were obtained from FtsW and FtsN depletion strains in which expression of the respective gene is under control of an arabinose-dependent promoter. Cells were grown at 37°C in LB medium containing antibiotics and 0.2% arabinose to an OD 600 of ϳ0.8. Arabinose was removed by washing the cells twice with LB medium. Washed cells were then used to inoculate 2 liters of LB medium to an initial OD 600 of 0.005. The LB medium contained antibiotics and either 0.2% arabinose or glucose to induce or repress, respectively, expression of the target fts gene. Cultures were grown to an OD 600 of about 0.7 (3.5 to 5 h), by which time the cells grown in LB medium with glucose were filamentous. Cells were harvested by centrifugation and resuspended in 15 ml of buffer 1 (50 mM Tris-HCl [pH 8.0], 50 mM NaCl, 1 mM EDTA). After addition of 1 l of Benzonase nuclease and lysozyme to 0.5 mg/ml, cells were broken by sonication. Unbroken cells and large debris were removed by low-speed centrifugation (8,000 ϫ g for 10 min, done twice), and then membranes were recovered by high-speed centrifugation (100,000 ϫ g for 75 min). The membrane pellet was resuspended in 20 ml of buffer 2 (20 mM Tris-HCl [pH 8.0], 25 mM NaCl, 0.5 mM EDTA) and centrifuged as described above. The washed membranes were resuspended in 800 l of buffer 2 and stored in aliquots at Ϫ70°C. The protein concentration was typically ϳ5 mg/ml, as determined by a Bradford assay with bovine serum albumin as the standard.
The rate of acylation of PBP3 with Bocillin FL was determined in buffer 2 at a membrane protein concentration of 1.25 mg/ml. Tubes containing membranes in buffer were prewarmed to 37°C, and then reactions were initiated by addition of 1/10 volume of Bocillin FL. Reactions were stopped by addition of an equal volume of 2ϫ Laemmli sample buffer and analyzed by SDS-PAGE and fluorescence imaging.
The rate of acylation with cephalexin was determined by competition with Bocillin FL. Membranes (membrane protein concentration of 1.25 mg/ml in buffer 2) were incubated for 30 min with 20 M Bocillin FL and various concentrations of cephalexin, which was unlabeled. Reactions were stopped with an equal volume of 2ϫ Laemmli sample buffer and analyzed as described above.
Determining the temperature stability of PBP3. Plasmids pDSW478 and pDSW514 express wild-type and mutant ftsI, respectively, under control of an arabinose-inducible promoter. Transformants were grown at 30°C to an OD 600 of ϳ0.1, and then arabinose was added to a final concentration of 0.2%. Cells were harvested 2 h after induction and resuspended in 100 l of BugBuster per ml of culture per OD 600 of 1.0 (typically 15 ml of culture was suspended in about 800 l of BugBuster). The BugBuster contained 25 U of Benzonase nuclease per ml. The suspension was incubated for 15 min at room temperature to extract soluble proteins, transferred to a microcentrifuge tube, and centrifuged for 1 min at 18,000 ϫ g. The pellet, which contained the membranes, was resuspended in 25 l of 50 mM Tris-HCl (pH 8.0) per ml of culture per OD 600 of 1.0. Membranes were preincubated at 42°C for various lengths of time, transferred to 30°C, and incubated with 10 M Bocillin FL for 20 min. The binding reaction was stopped by addition of Laemmli sample buffer and analyzed by SDS-PAGE and fluorescence imaging.
Detection and quantification of Bocillin FL bound to PBPs. Labeled proteins were separated on SDS-12% polyacrylamide gels and detected with a Typhoon 8600 imager (Amersham Pharmacia Biotech, Piscataway, N.J.). The instrument settings for gel scanning were as follows: excitation laser, 532-nm-wavelength light; short pass emission filter, 526 nm-wavelength light; photomultiplier, 800 V; and pixel size, 100 m. ImageQuant software was used to quantify the fluorescence signal. In some cases, such as Fig. 2B and Table 2 , the fluorescence of the PBP2 band was used to normalize the signal from PBP3. Because PBP2 does not bind cephalexin, lane-to-lane differences in PBP2 fluorescence signal reflected sample handling errors. None of the conclusions reached in this study would be different if normalization was not done, but the standard deviations reported would be somewhat larger.
Western blotting. Samples were transferred to nitrocellulose membranes, and PBP3 was detected with a polyclonal antibody essentially as described previously (42) .
RESULTS
Penicillin-binding assays in growing cells. We sought to test the idea that the catalytic activity of PBP3 is low in nondividing cells, where the protein is distributed around the membrane, but high in dividing cells, where the protein is localized to the division site and presumably makes contact with other division proteins. To test this hypothesis, we employed three ␤-lactams that bind selectively to PBP3, aztreonam, piperacillin, and cephalexin, because they could be added to growing cells without inducing rapid lysis. Previous studies have shown that piperacillin and aztreonam readily acylate PBP3 even at low concentrations, while cephalexin is a very weak acylating agent (1). It is important to realize that although the assay is traditionally called a "binding" assay, formation of an acyl enzyme complex requires that the protein perform catalysis on the ␤-lactam. Figure 2 presents results obtained when cells were depleted of FtsW, a membrane protein suspected of interacting directly with PBP3 (23) . To do this assay, a strain engineered to express ftsW under control of an arabinose-dependent promoter was grown in LB medium containing arabinose or glucose until the glucose-grown cells became visibly filamentous; the average lengths were 3.3 and 10.2 m for cells grown in LB medium containing arabinose and glucose, respectively. Then cephalexin was added to both cultures, and growth continued for 30 min; the final lengths were 5.6 and 19.3 m, respectively (the arabinose-grown cells became filamentous because cephalexin inactivates PBP3). Cells were harvested, and the residual unacylated PBPs were detected with Bocillin FL.
Cephalexin appeared to acylate PBP1b, PBP3, and PBP4 under these conditions (Fig. 2A) . Visual inspection of the gels suggested somewhat more Bocillin FL binding to PBP3, and therefore less cephalexin binding, in the filaments grown in glucose compared to the cells grown in arabinose. This trend was more apparent at relatively low cephalexin concentrations such that only about half of the PBP3 was acylated. For example, when the cells were grown with 5 g of cephalexin per ml, about 60% of the PBP3 in arabinose-grown cells was acylated, compared to about 40% in glucose-grown filaments (Fig. 2B) . This difference, although small, was found to be statistically significant in a Welch two-sample t test (60% Ϯ 6.0% versus 42% Ϯ 3.6% [n ϭ 6] [P Ͻ 0.001]). At high cephalexin concentrations, almost all of the PBP3 was acylated, regardless of the division status of the culture. A time course of cephalexin binding to PBP3 appeared somewhat biphasic, with an initial rapid increase in acylation followed by a longer period during which the level of acylation appeared to approach a plateau (Fig. 2C) . The reason for the plateau is not known but might reflect a steady state during which the rate of cephalexin binding is balanced by synthesis of new (unacylated) PBP3 in the growing cells (21) .
Loss of PBP1b signal was surprising, as this protein is not reported to have a high affinity for cephalexin. Curiously, PBP1b appeared to bind cephalexin only when Bocillin FL counterlabeling was done with detergent-extracted membranes. Similar assays performed with spheroplasts did not imply acylation of PBP1b with cephalexin, nor did we see cephalexin binding to PBP1b in membranes isolated from sonicated cells (data not shown). Therefore, we suspect that PBP1b was lost or inactivated during sample work-up rather than acylated. There is evidence that sometimes PBP1b forms a complex with several other proteins involved in peptidoglycan synthesis, including PBP3 (39) . Perhaps binding of cephalexin to PBP3 alters this complex in a way that renders PBP1b more labile. Regardless of the underlying mechanism, in those assays in which we did see loss of PBP1b signal, it was not correlated with the cell division status of the culture, so we did not study it further.
Binding of cephalexin to PBP4 was consistently observed and has been reported previously (10) . Cephalexin acylated PBP4 equally well in dividing and nondividing populations, consistent with previous evidence that this protein is not required for cell division (12) . (In Fig. 2A , it appears that slightly less PBP4 bound cephalexin in the glucose-grown filaments, but this is an artifact of loading differences. When normalized to PBP2, the fluorescence signals for a given cephalexin concentration agree to within 5% in all cases [data not shown].) Similar experiments were performed with aztreonam and piperacillin. Each of these antibiotics was highly specific for PBP3 under the conditions used. The extents of binding to (Table 2) . In all cases, PBP3 was less reactive towards cephalexin in filamentous cells than in dividing cells. As with depletion of FtsW, the difference was apparent only at cephalexin concentrations that resulted in roughly 50% saturation of PBP3.
We changed several experimental parameters in an effort to increase the difference in the reactivity of PBP3 towards cephalexin in dividing cells compared to that in nondividing cells. These changes included prolonging the incubation time with cephalexin, letting the filamentous cells get longer before adding the cephalexin, and adding a protein synthesis inhibitor shortly before harvesting the cells. In each case, the difference in cephalexin binding observed was comparable to that reported above (data not shown). We also investigated the effects of expressing PBP3 from a plasmid, but the data could not be interpreted because overproduction of PBP3 resulted in the appearance of multiple bands that interfered with accurate bookkeeping. This problem prevented us from assaying mutant forms of PBP3 that are defective in localization and might be expected to bind cephalexin slightly less well than the wild type, at least when expressed at physiologically appropriate levels in growing cells.
Western blotting was used to investigate whether reduced acylation of PBP3 in filamentous cells might be due to changes in the amount of protein. Although there was some lane-tolane variation in the PBP3 signal in these blots, it did not correlate with filamentation or cephalexin treatment (Fig. 3) . We conclude that the variation seen reflects errors in sample handling and efficiency of protein transfer to membranes, not systematic differences in the amount of PBP3. In support of this interpretation, the strength of the PBP3 signal seen in Western blots was usually correlated with the strength of the PBP2 signal seen in Bocillin FL-binding assays (data not shown). Additional evidence that blocking division does not alter the amount of PBP3 was obtained when Bocillin FL binding was investigated in isolated membranes (see below).
Penicillin-binding assays in isolated membranes. We attempted to extend our observations to a simpler experimental system by assaying ␤-lactam binding to PBP3 in isolated membranes prepared from strains depleted of FtsW and FtsN. The FtsW depletion strain was grown in LB medium containing arabinose and LB medium containing glucose, and membranes were isolated from the resultant normal cells and filaments, respectively. At the time of harvest, the average length of arabinose-grown cells was 2.9 m, while the average length of glucose-grown cells was 25.2 m. Since we do not have an antibody against FtsW, we could not assess directly the levels of FtsW in these preparations.
The apparent rate of acylation of PBP3 with Bocillin FL was not affected by depletion of FtsW (Fig. 4A) . It is worth noting that this assay was done with equal amounts of total membrane protein, so the fact that the binding curves are essentially superimposable indicates that depletion of FtsW did not cause a change in the amount of PBP3. To assay cephalexin binding, we used a competition assay in which membrane proteins were incubated for 30 min with 20 M Bocillin FL and various concentrations of (unlabeled) cephalexin. Depletion of FtsW had no effect on the concentration of cephalexin needed to reduce Bocillin FL binding by 50% in this assay. The values obtained were 155 Ϯ 29 and 166 Ϯ 22 M for FtsW-replete and -depleted membranes (mean Ϯ standard deviation for six assays; 160 M cephalexin ϭ 55 g/ml).
Next, we tested FtsN, another division protein considered likely to interact directly with PBP3 (2, 11). An FtsN depletion strain was grown on LB medium containing arabinose and LB medium containing glucose, and membranes were isolated from the resulting cells (average length, 2.6 m) and filaments (average length, 21.4 m). Since we have an antibody against FtsN, Western blotting was used to assess the level of this protein in the two membrane preparations. We also included a wild-type strain of E. coli in this comparison, because the depletion strain carries ftsN on a plasmid and is therefore expected to overproduce the protein. Western blotting of various dilutions of these membranes indicated that arabinose- Table 2 were analyzed by Western blotting with a chemiluminescent substrate and exposure to film. Only the portion of the blot with PBP3 is shown. a Cephalexin was used at a concentration of 10 g/ml, and Bocillin FL counterlabeling was done with spheroplasts rather than envelopes prepared by detergent extraction as in Fig. 2 .
b Mean Ϯ standard deviation given for strains EC297, EC433, and JOE565 for which more than one experiment was performed.
grown cells had about 50-fold more FtsN than normal, while glucose-grown cells had about 50-fold less FtsN than normal (data not shown).
The rate of acylation of PBP3 with Bocillin FL was not affected by depletion of FtsN (Fig. 4B) . Likewise, competition assays failed to reveal any effect of FtsN depletion on acylation with cephalexin. The concentrations of cephalexin required to reduce acylation of PBP3 with Bocillin FL by 50% were 184 Ϯ 22 and 185 Ϯ 46 M for membranes with and without FtsN, respectively (four experiments).
Analysis of the ftsA3(Ts) E. coli strain D-3. Our inability to find evidence that depletion of FtsW or FtsN prevents binding of ␤-lactams to PBP3 in isolated membranes was troubling in view of a previous report that inactivation of ftsA can abolish the ability of PBP3 to acylate itself with ampicillin (36) . FtsA is an early recruit to the division site and therefore is less likely than FtsW or FtsN to interact directly with PBP3, a late recruit (Fig. 1) . We therefore decided to reinvestigate the ftsA3(Ts) mutant.
Strain D-3, which was used in the previous study, was obtained from the E. coli Genetic Stock Center at Yale University. We confirmed that this strain formed colonies on LB agar at 30°C, but not at 42°C, and that colony formation could be rescued by plasmid pBS58, which carries ftsQAZ (4). We also amplified the ftsA gene by PCR and confirmed the presence of the previously reported mutation, C7193T, which changes threonine 240 to isoleucine (32) . Finally, we used Bocillin FL to confirm that acylation of PBP3 was significantly reduced when membranes from strain D-3 were preincubated at 42°C and that loss of activity could not be attributed to the loss of PBP3 protein as judged by Western blotting. Other PBPs from strain D-3 were not significantly affected by incubation at 42°C. Likewise, PBP3 from a wild-type strain was not much impaired by this treatment. Taken together, these results confirm the previously reported observations (36) .
We then considered the possibility that this apparent ftsA3(Ts) effect might be due instead to a cryptic temperaturesensitive mutation in ftsI, which encodes PBP3. The ftsI gene from strain D-3 was amplified by PCR and cloned into a plasmid vector. Plasmids derived from two independent amplifications were used for DNA sequencing and revealed three ftsI mutations: C8613T, which is silent; C11143T, which changes Pro372 to Ser; and C16753T, which changes Arg559 to Cys. Both amino acid substitutions are in the penicillinbinding (transpeptidase) domain (26) . We designated this allele ftsI321.
To determine whether the ftsI321 allele encodes a thermolabile PBP3, we subcloned the relevant portion of the mutant gene into an arabinose-based expression vector for wild-type ftsI. Both expression vectors were transferred into DHB4, a strain not known to have any mutations affecting cell division. Isolates were grown at 30°C and induced with arabinose to overproduce the plasmid-encoded PBP3. This results in roughly 50-fold overproduction of PBP3 (data not show), so the presence of a small amount of chromosomally encoded wildtype PBP3 from the host strain does not affect subsequent assays. Cells were harvested, and membranes were prepared by extraction of soluble proteins with a nonionic detergent. Membranes were preincubated at 42°C for various lengths of time, transferred to 30°C, and assayed for binding of Bocillin FL. The half-life of the mutant PBP3 at 42°C was about 6 min, whereas that of the wild-type PBP3 was about 50 min (Fig. 5) . We infer that ftsI321 encodes a thermolabile PBP3 and that the ftsA3(Ts) allele has no effect on the penicillin-binding activity of PBP3 in isolated membranes.
DISCUSSION
Penicillin-binding assays as probes of transpeptidase catalytic activity. These studies were undertaken to test the idea that interactions between PBP3 and other division proteins stimulate PBP3's transpeptidase activity during cell division. The underlying assumption in our approach is that transpeptidase activity will be reflected in reactivity towards ␤-lactams. This assumption is probably valid only for some aspects of the transpeptidation reaction. For example, if the catalytic serine is occluded or not activated as a nucleophile or if the oxyanion hole that stabilizes the transition state is not formed in the enzyme, then the rate of acylation will probably be negligible with ␤-lactams or the authentic peptide substrates. However, because the peptide substrates are much larger than ␤-lactams, some conformations of the enzyme that do not bind the peptides might still bind the antibiotics, and different ␤-lactams might bind differently and therefore give different results. Finally, penicillin-binding assays as performed here give no information on the second step (deacylation) of the transpeptidase reaction. The ftsA3(Ts) strain D-3 contains a thermolabile PBP3. When we initiated these studies, the most compelling evidence for regulation of the catalytic activity of PBP3 by another division protein was the report that inactivation of the ftsA3(Ts) allele abolished penicillin binding to PBP3 (36) . We found this interpretation to be in error; the strain employed in those studies harbors a thermolabile PBP3 with two amino acid substitutions in the transpeptidase domain. The ftsA3(Ts) mutation was induced with nitrosoguanidine, which is known to cause frequent secondary mutations (13, 14) .
Penicillin-binding assays in isolated membranes. Based on the results of localization studies, the two division proteins most likely to interact directly with PBP3 are FtsW and FtsN (2, 23) . Accordingly, we isolated membranes from FtsW and FtsN depletion strains and assayed acylation of PBP3 with Bocillin FL and cephalexin. Depletion of FtsW or FtsN did not appear to affect the rate of acylation with either antibiotic. Either FtsW and FtsN do not regulate the transpeptidase activity of PBP3, or if they do, regulation occurs only in the context of protein complexes that are lost during membrane isolation. The latter possibility must be taken seriously in view of the evidence from protein localization studies that recruitment of division proteins to the septal ring depends on the presence of an FtsZ ring (30) . Our membrane preparations lack FtsZ.
Penicillin-binding assays in growing cells. Using ␤-lactams to probe the catalytic activity of PBP3 in growing cells makes it possible to assay the enzyme under conditions in which it is active in cell wall synthesis. These conditions cannot be replicated in vitro yet (1) . We found that inhibition of cell division by a variety of methods had no detectable effect on the apparent rate of acylation of PBP3 with aztreonam or piperacillin but slightly reduced acylation with cephalexin. The magnitude of the effect observed with cephalexin depended upon the assay conditions, especially the concentration of antibiotic, but is likely to be in the range of 1.5-to 2-fold. The lower value is based on the observation of about 60 to 80% acylation of PBP3 with 5 to 10 M cephalexin in dividing cells, compared to about 40 to 60% in filaments ( Fig. 2 and Table 2 ). The higher value takes into consideration that in an E. coli population growing with a doubling time of about 30 min, only about half of the cells exhibit septal localization of PBP3 (41) (42) (43) . While an effect of twofold or less is small, we think it is likely to be an underestimate. If PBP3 is engaged in cell wall synthesis in the dividing population, then peptide substrates are probably competing with cephalexin for access to the active site. Protection of the enzyme by peptide substrates has been invoked previously to explain why the MICs for some ␤-lactams are higher than would be expected on the basis of binding affinities determined in isolated membranes (7, 21) .
We infer that the catalytic site of PBP3 is properly assembled even in nondividing cells, when PBP3 does not appear to be engaged in cell wall synthesis. If the catalytic site adopted a different (presumably more active) conformation when PBP3 engages other proteins at the division site, we would have expected to see much faster acylation with all three antibiotics in dividing populations compared to nondividing populations. However, the finding that acylation with cephalexin is somewhat sensitive to the division status of the cells suggests that some aspect of PBP3 function is modulated by interaction of PBP3 with other division proteins. We suggest that this is substrate binding and that the small effect seen with cephalexin might reflect a much larger effect on binding of the authentic peptide substrates used in cell wall synthesis. Several of our observations are consistent with this interpretation, including lack of a difference in acylation rate in isolated membranes (no complexes present under these conditions regardless of the presence or absence of FtsW or FtsN), lack of a difference in acylation rate at high cephalexin concentrations (which overcome weak binding), and lack of a difference in acylation rate with aztreonam or piperacillin (these antibiotics bind differently to the enzyme than cephalexin does).
Genetic studies support the notion that the binding site for cephalexin overlaps but is not identical to those for peptide substrates and that the binding site for cephalexin differs in important respects from those for aztreonam and piperacillin. Hedge and Spratt selected for E. coli mutants resistant to cephalexin and obtained strains with lesions in the transpeptidase domain of PBP3 (18, 19) . Despite extensive efforts, only a few mutations that resulted in substantial cephalexin resistance were recovered, implying that very few amino acids in PBP3 can be changed to reduce the affinity for cephalexin without compromising transpeptidation. In other words, the binding sites for cephalexin and peptide substrates are similar but not identical. Perhaps more surprising was the finding that cephalexin-resistant mutants that produced an altered PBP3 with about 500-fold-lower affinity for cephalexin have no detectable cross-resistance against aztreonam or piperacillin. A few less-interesting hypotheses might also account for faster acylation of PBP3 in dividing cells than in nondividing cells. One potential explanation is that the cephalexin concentration in the periplasm of filaments might be lower. This would be the case if filamentation retarded diffusion of cephalexin into the periplasm, enhanced efflux, or stimulated a ␤-lactamase. However, if a lower cephalexin concentration in the periplasm were the basis of our observations, we would expect to see reduced acylation of PBP4, which we do not. PBP4 reportedly binds cephalexin less well than PBP3 (10), so it should be more sensitive than PBP3 to the antibiotic concentration. In addition, most mechanisms of excluding cephalexin would also be likely to exclude aztreonam or piperacillin to some extent, but no evidence for reduced binding of these antibiotics was obtained, even at subsaturating concentrations (Fig. 2B) . Another potential explanation for slower acylation with cephalexin in filaments than in dividing cells would be differences in the amount of PBP3 in two cell types, but this hypothesis is hard to reconcile with the finding that acylation with aztreonam and piperacillin was not reduced in the filaments (Fig. 2B) . Moreover, direct measurements of PBP3 levels by Western blotting (Fig. 3) and penicillin-binding assay ( Fig. 2A and Fig. 4 ) did not reveal any consistent differences in PBP3 levels that could be correlated with filamentation or cephalexin treatment.
It is interesting that the reactivity of PBP3 towards cephalexin was reduced by inactivation or depletion of proteins needed for recruitment of PBP3 to the septal ring (FtsZ, FtsA, FtsQ, and FtsW) as well as by depletion of a protein (FtsN) that localizes after PBP3. This finding implies that localization of PBP3 is not sufficient for activating the transpeptidase activity.
Comparison to serine proteases. An analogy can be made to the serine proteases, which employ a catalytic mechanism similar to that of the PBPs and are subject to inactivation by small molecule inhibitors, such as diisopropylphosphofluoridate (DFP). DFP forms a relatively long-lived covalent adduct with the catalytic serine, but essentially it does so only if the enzyme is active as a protease. Thus, zymogens do not react readily with inhibitors that modify the catalytic serine. For example, chymotrypsin reacts about 4 orders of magnitude more rapidly with DFP than does chymotrypsinogen (25) , because in the latter the oxyanion hole involved in transition state stabilization is not formed (40) .
Other modes of regulation. Allosteric interactions that activate the catalytic function of PBP3 during division are an attractive, but by no means the only, way to spatially and temporally regulate the transpeptidase. There is evidence to suggest that PBP3 uses a special substrate for the transpeptidation reaction (3), although this has been questioned (12, 38) . In addition, it is worth noting that the reaction catalyzed by PBP3 is unusual in that both the enzyme and its substrates are fixed in space, so conformation changes brought about by various Fts proteins during division might give PBP3 access to the transpeptidation substrates without affecting the structure of the active site per se. Either of these alternative modes of regulation could effectively restrict enzyme activity in time and space but would not be reflected in different reactivities towards freely diffusible artificial substrates such as ␤-lactams.
